T
TENX
Tenax Therapeutics Inc
14.43
-0.54-3.58%After Hours: 14.33 -0.10 -0.66%17:36 04/10 EDT
OPEN/PREV CLOSE14.92/14.96
TODAY RANGE13.94-15.05
VOL198.20K
MARKET CAP248.08M
52 WEEK RANGE4.630-18.38
AVG VOL (3M)358.06K
% TURNOVER1.15%
TURNOVER--
P/E (TTM)-10.7553
% RANGE7.39%
EPS(TTM)-1.3412
P/E(FORWARD)0.0002
P/B1.384
BVPS10.42
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP83.45M
SHARES OUTSTANDING17.20M
NEXT EARNINGS05/12-05/18
FREE FLOAT5.79M
LOT SIZE1
EX-DATE01/03/2024
News
Press Releases
Financial Reports
Profile
NASDAQ·03/27 03:14
Tenax Therapeutics (TENX) Price Target Increased by 13.86% to 29.32
TipRanks·03/25 12:38
Four new option listings on March 25th
TipRanks·03/24 15:45
Tenax Therapeutics files $300M mixed securities shelf
Benzinga·03/24 15:44
Tenax Therapeutics Files Prospectus For Offering $300M Securities
Reuters·03/24 15:42
TENAX THERAPEUTICS INC - MAY OFFER UP TO $300 MLN OF SECURITIES - SEC FILING
Seeking Alpha·03/18 16:06
Tenax Therapeutics: A Binary Bet With Heavy Downside Likely
Seeking Alpha·03/17 15:57
Tenax wins bullish view at Cantor ahead of pivotal readout
TipRanks·03/17 13:36
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
Dow Jones·03/17 12:50
Tenax Therapeutics Initiated at Overweight by Cantor Fitzgerald
Dow Jones·03/17 12:50
Tenax Therapeutics Price Target Announced at $35.00/Share by Cantor Fitzgerald
Benzinga·03/17 12:45
This Ingredion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
TipRanks·03/17 11:31
Cantor starts Tenax at Overweight into Phase 3 readout